Get started
Author

Nora Astrain-Redín

Observed names: Astráin-Redín, N. (Nora), Nora Astrain, Nora Astrain-Redin
ORCID: 0000-0001-8593-8994
Observed ORCID: 0000-0001-8593-8994
OpenAlex ID: A5065610222
From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment
2023 · Nora Astrain-Redin, Carmen Sanmartin, et al. · Journal of Medicinal Chemistry · 56
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
2023 · Nora Astrain-Redin, Niccolò Paoletti, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 23
PDF
Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds
2023 · Nora Astrain-Redin, Irene Talavera, et al. · Antioxidants · 18
PDF
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
2021 · Mikel Etxebeste-Mitxeltorena, Daniel Plano, et al. · Antioxidants · 13
PDF
Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity
2023 · Nora Astrain-Redin, Asif Raza, et al. · Antioxidants · 11
PDF
Synthesis and Preclinical Development of novel Organoselenium compounds as Multi-Target and Bioactive Agents
2023 · Astráin-Redín, N. (Nora) · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
Abstract 6356: Discovery of seleno allyl hybrid compounds, the Se incorporated mimics of naturally occurring garlic based allylic compounds, as potential anticancer agents
2020 · Irene Talavera, Nora Astrain, et al. · Cancer Research
Works count: 7
Citation count: 121
H-index: 5
I10-index: 5
Year
Topic
Type